Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine for postoperative sedation after intracranial hemorrhage evacuation
ChiCTR-IPR-15006668Phase 4Not yet recruiting
- Sponsor
- Southern District of Anhui Provincial Hospital
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in intracerebral hemorrhage (ICH) (2 arms), sponsored by Southern District of Anhui Provincial Hospital. Primary endpoints: Blood pressure, Heart rate and 1 more. Planned start Jul 2015; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on ChiCTR-IPR-15006668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006668.